Hospital
Public Health Trust of Miami Dade County Florida
Public Health Trust of Miami Dade County Florida was paid $1.98M by Medicaid between Aug 2021 and Nov 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoPUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA
DORAL, FL 33122
DORAL, FL 33122
33aNPI1639783509assigned 09/08/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$1.98M
24GClaims87,772
24DCodes billed92
24AFirst – last monthAug 2021 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#119 of 163
Median peer was paid$4.77M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KNIGHT, MARK controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 8,890 | $156K | |
| 2022 | 38,165 | $994K | |
| 2023 | 24,464 | $632K | |
| 2024incomplete | 16,253 | $199K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 4,996 | 4,313 | $489K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 5,134 | 4,330 | $462K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 3,348 | 2,071 | $257K |
| G0378 | Hospital observation service, per hour | 9.3% | 3,632 | 1,586 | $185K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.6% | 521 | 456 | $151K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 7.5% | 520 | 501 | $149K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.4% | 372 | 311 | $87K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.6% | 577 | 502 | $51K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 783 | 572 | $49K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 59 | 57 | $17K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 75 | 63 | $16K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 595 | 500 | $16K |
80 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,420 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 617 | $9K |
| 80053 | Comprehensive metabolic panel | <1% | 6,768 | $5K |
| 84484 | <1% | 4,236 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 11,294 | $3K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 640 | $2K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 190 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 251 | $2K |
| 97162 | <1% | 158 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 77 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 357 | $846.64 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,543 | $760.62 |
| 71045 | Radiologic examination, chest; single view | <1% | 2,316 | $646.89 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,118 | $609.83 |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,066 | $553.36 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 18 | $546.43 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,383 | $544.02 |
| 86850 | <1% | 543 | $535.47 | |
| 86803 | <1% | 804 | $531.24 | |
| 85610 | <1% | 1,957 | $505.75 | |
| 85730 | <1% | 1,696 | $485.23 | |
| 81001 | <1% | 4,027 | $477.38 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 694 | $446.38 |
| 86703 | <1% | 749 | $416.94 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 777 | $391.50 |
| 86900 | <1% | 592 | $381.94 | |
| 86901 | <1% | 592 | $381.94 | |
| 83735 | <1% | 2,062 | $324.27 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,486 | $315.17 |
| J3490 | Unclassified drugs | <1% | 569 | $315.17 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 108 | $246.93 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 159 | $186.51 |
| 84703 | <1% | 1,454 | $166.01 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 612 | $142.57 |
| 83880 | <1% | 823 | $77.80 | |
| 83690 | <1% | 1,345 | $60.50 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 22 | $48.70 |
| 84100 | <1% | 318 | $36.00 | |
| 76801 | <1% | 66 | $32.64 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 198 | $21.37 |
| 80076 | <1% | 458 | $16.86 | |
| 83605 | <1% | 524 | $16.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 110 | $13.50 |
| 87186 | <1% | 232 | $13.00 | |
| 87040 | <1% | 379 | $8.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 45 | $7.50 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 15 | $4.55 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,541 | $3.45 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 634 | $3.31 |
| 86140 | <1% | 176 | $3.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 699 | $3.31 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 385 | $2.27 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 418 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 31 | $0.00 |
| 84702 | 0% | 537 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 417 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 130 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 144 | $0.00 |
| 81025 | 0% | 52 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 287 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 81 | $0.00 |
| 73610 | 0% | 14 | $0.00 | |
| 85007 | 0% | 65 | $0.00 | |
| 85379 | 0% | 61 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 212 | $0.00 |
| 87077 | 0% | 232 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 345 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 95 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 313 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 66 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 68 | $0.00 |
| 82550 | 0% | 92 | $0.00 | |
| 97166 | 0% | 16 | $0.00 | |
| C9399 | Unclassified drugs or biologicals | 0% | 45 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 13 | $0.00 |
| 85652 | 0% | 31 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 34 | $0.00 |
| 88304 | 0% | 32 | $0.00 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 13 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKNIGHT, MARK (EVP CFO)
Parent organizationPUBLIC HEALTH TRUST OF MIAMI DADE COUNTY FLORIDA
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.